tirzepatide impurities Compounded versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said patientsafety #glp1 #tirzepatide #obesitymedicine #elililly

Rosenstock, J., Frias, J., Jastreboff, A

In the original characterization, the compound released GH from cultured rat pituitary cells with an EC50 in the low-nanomolar range and raised GH in dogs after oral doses as low as 0.125 mg/kg, which is why it was selected for clinical study

For many patients, the compounded route makes clinically appropriate treatment durations financially feasible where brand-name versions would not

If anything arises, report those changes to your medical provider 73

All doses, same price

These claims aim to hold the drug manufacturers accountable for the adverse effects experienced by patients